Hermetica Superfood Encyclopedia
The Short Answer
Matisi (Leucaena leucocephala) contains triterpenoids (lupeol, betulin), phytosterols (β-sitosterol), polyphenols, condensed tannins, and flavonoids that exert antioxidant activity via radical scavenging and exert putative anticancer and antibacterial effects through molecular interactions with Topoisomerase II, DNA gyrase, and AKT1 signaling. Pod extracts demonstrated DPPH radical scavenging with an IC50 of 38.68 ± 0.20 µg/mL in vitro, and stem bark—the part used in Samoan wound care—is particularly enriched in β-sitosterol (27.2%), betulin (22.1%), and lupeol (21.1%) by GC-MS peak area.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordmatisi Leucaena leucocephala benefits
Matisi — botanical close-up
Health Benefits
**Wound Healing Support (Traditional)**
The stem bark is applied topically in Samoan ethnomedicine for wounds, with β-sitosterol (27.2%), betulin (22.1%), and lupeol (21.1%) identified as likely contributors to anti-inflammatory and tissue-repair activity via NF-κB modulation and collagen synthesis support.
**Antioxidant Activity**
Methanolic leaf extracts contain condensed tannins at 137.52 ± 92.74 mg catechin equivalents/g and total tannins at 209.05 ± 7.49 mg TAE/g, conferring robust DPPH and ABTS radical scavenging capacity that may protect cells from oxidative damage.
**Antimicrobial Potential**
In silico molecular docking of pod compounds—including sophoranone and oxmetidine—against bacterial DNA gyrase revealed strong binding affinities, suggesting a mechanistic basis for the traditional use of the plant in infection management.
**Putative Anticancer Activity**
Compounds identified in pod extracts via LC-MS (54 compounds including atovaquone and hodgkinsine) demonstrated stable binding to Topoisomerase II and AKT1 in molecular dynamics simulations, indicating potential for antiproliferative effects, though no in vivo or clinical confirmation exists.
**Anti-inflammatory Properties**
Lupeol, a prominent triterpenoid in leaves (14.7%) and stem bark (21.1%), is a recognized inhibitor of inflammatory pathways including NF-κB and COX-2, potentially underpinning the plant's use in pain and wound management across Pacific traditional systems.
**Phytosterol-Related Cardiovascular and Metabolic Support**: The high β-sitosterol content—particularly in fruits (55.7% by GC-MS peak area)—aligns with established phytosterol mechanisms of cholesterol absorption inhibition at the intestinal brush border, though this has not been clinically tested specifically for matisi.
**Digestive and Reproductive Ethnopharmacology**
Traditional Samoan and Pacific Island uses include treatment of stomach ache, and the plant has been documented as a contraceptive and abortifacient, effects potentially mediated by alkaloids such as mimosine and steroidal constituents that may influence smooth muscle and hormonal signaling.
Origin & History
Natural habitat
Leucaena leucocephala is native to southern Mexico and Central America but has naturalized extensively across the Pacific Islands, Southeast Asia, Africa, and tropical regions worldwide, where it thrives in disturbed soils, roadsides, and secondary forests at low to mid elevations. In Samoa and other Pacific Island nations, it is a common agroforestry and fallow species known locally as matisi, valued both as fodder and in traditional medicine. The plant is a fast-growing leguminous shrub or small tree tolerant of drought and poor soils, making it ecologically dominant in many tropical environments.
“Leucaena leucocephala has been integrated into Pacific Island ethnomedicine, particularly in Samoa where the bark (matisi) is applied to wounds, and its use extends across tropical regions of Asia, Africa, and Latin America where it has naturalized. Traditional Polynesian and Pacific ethnobotanical records document its use for stomach ache and as a contraceptive and abortifacient, reflecting broad historical recognition of its biologically active properties—likely related to its mimosine alkaloid and steroidal content. In its native range of Mesoamerica, indigenous communities historically used related Leucaena species in food and medicine, and the plant was spread globally by colonial-era agroforestry initiatives as a nitrogen-fixing fodder crop, facilitating its adoption into local healing traditions wherever it naturalized. Preparation in traditional contexts typically involves simple decoctions or direct topical application of bark and leaf material, consistent with the observation that even aqueous extracts retain measurable tannin and polyphenol concentrations.”Traditional Medicine
Scientific Research
The available evidence base for Leucaena leucocephala is entirely preclinical, consisting of in vitro antioxidant assays, GC-MS and LC-MS phytochemical profiling, and computational in silico molecular docking and dynamics studies; no human clinical trials, randomized controlled trials, or animal intervention studies with quantified outcomes have been published on matisi specifically in the context of its traditional Samoan applications. GC-MS analysis of leaves, fruits, and stem barks provided compound identification and relative peak area percentages, while spectrophotometric methods quantified tannins, polyphenols, and flavonoids across solvent systems, revealing that organic solvents (methanol, ethanol) yield substantially higher bioactive content than aqueous extraction. Molecular docking of 54 LC-MS-identified pod compounds against Topoisomerase II, DNA gyrase, and AKT1 targets provided in silico evidence for antibacterial and anticancer binding potential, corroborated by molecular dynamics simulations, but these findings have not been validated in cell-based assays or animal models. Overall, the evidence is preliminary and exploratory; the large standard deviations in tannin measurements (e.g., 137.52 ± 92.74 mg Cat E/g) suggest significant variability in extract composition, and translation to human therapeutic outcomes remains entirely unestablished.
Preparation & Dosage
Traditional preparation
**Traditional Bark Poultice (Samoan Wound Use)**
Fresh or dried stem bark is prepared as a topical application; specific quantities and preparation protocols are not formally documented in ethnobotanical literature but likely involve mashing or decoction of bark applied directly to wounds.
**Methanolic Leaf Extract (Research Standard)**
49 mg TAE/g) and polyphenol content; no therapeutic dose established
Studies use methanol extraction (e.g., 30:70 v/v ethanol:water or pure methanol) of dried leaf powder, yielding the highest tannin (209.05 ± 7..
**Ethanolic Extract**
74 mg Cat E/g) and is considered the practical alternative to methanol for research purposes; again, no human dose defined
Ethanolic extraction yields comparable condensed tannins (140.22 ± 92..
**Aqueous Decoction**
49 mg TAE/g; total polyphenols 1
Water-based extraction—historically the most accessible preparation method—yields substantially lower bioactive concentrations (total tannins 55.85 ± 7..32 ± 0.11 mg GAE/g) and is the most likely traditional preparation route.
**No Commercial Supplement Forms Documented**
Matisi is not available as standardized capsules, tablets, or tinctures in the commercial supplement market, and no pharmacopoeial monograph or standardization percentage has been established.
**No Established Human Dose**
Human-effective dose ranges, bioavailability data, and optimal timing have not been determined; all extract concentrations reported are for in vitro experimental conditions only.
Nutritional Profile
Leucaena leucocephala leaves are known to contain approximately 20–30% crude protein on a dry-weight basis (documented in agroforestry literature), making them a significant fodder source, though nutritional profiling in the context of human supplementation is limited. Phytochemical profiling identifies the dominant bioactive classes as condensed tannins (up to 209.05 mg TAE/g dry extract), total polyphenols (up to 5.74 mg GAE/g), and flavonoids (pods: 77.95 ± 0.32 mg QE/g), alongside fatty acids including linolenic acid methyl ester (Z,Z,Z-9,12,15-octadecatrienoic acid, 11.6% in leaves) and linoleic acid methyl ester (8.8% in bark). Phytosterols—particularly β-sitosterol (up to 55.7% of GC-MS peak area in fruits), stigmasterol (12.8%), and campesterol (7.6%)—are present at quantifiable levels, and bioavailability of phytosterols is generally low (estimated 5–15% intestinal absorption in humans based on class data). The plant also contains mimosine, a non-protein amino acid and known anti-nutritional factor and potential toxin, which limits raw consumption and requires consideration in any preparation.
How It Works
Mechanism of Action
The antioxidant activity of Leucaena leucocephala is primarily attributed to its dense polyphenolic content—total tannins reaching 209.05 mg TAE/g in methanolic leaf extracts—which donate hydrogen atoms to neutralize reactive oxygen species through electron-transfer and hydrogen atom-transfer mechanisms quantified by DPPH and ABTS assays. The triterpenoids lupeol and betulin, abundant across all plant parts (leaves 14.7% and 15.7%; stem bark 21.1% and 22.1% by GC-MS), inhibit pro-inflammatory transcription factors NF-κB and downstream mediators including COX-2 and TNF-α, mechanisms well-characterized for these pentacyclic triterpenes across multiple plant genera. In silico molecular docking and molecular dynamics studies of pod-derived compounds revealed that atovaquone, sophoranone, and oxmetidine bind stably to Topoisomerase II and DNA gyrase—bacterial and eukaryotic enzymes critical for DNA replication—with simulations showing stable RMSD, RMSF, hydrogen bonding patterns, and solvent-accessible surface area (SASA) profiles consistent with sustained inhibitory interactions, supporting antibacterial and antiproliferative hypotheses. β-Sitosterol acts at the intestinal level by competing with dietary cholesterol for micellar incorporation and NPC1L1-mediated uptake, while also modulating AKT1 and MAPK pathways implicated in cell proliferation based on receptor binding data from pod extract docking studies.
Clinical Evidence
No human clinical trials investigating Leucaena leucocephala (matisi) for any indication have been identified in the published literature; the entirety of the pharmacological evidence derives from in vitro and in silico studies without controlled human subjects. Antioxidant endpoints have been quantified in cell-free assays (DPPH IC50 38.68 ± 0.20 µg/mL for pod extracts), and computational studies provide mechanistic hypotheses regarding antimicrobial and anticancer activity, but these do not constitute clinical evidence of efficacy or safety. Traditional Samoan and Pacific Island ethnobotanical records document use of the bark for wounds and other applications, representing observational historical data rather than controlled outcomes. Confidence in therapeutic recommendations is very low; the ingredient should be regarded as a candidate for preclinical and early-phase clinical investigation rather than an evidence-supported intervention.
Safety & Interactions
The most significant safety concern with Leucaena leucocephala is the presence of mimosine, a toxic non-protein amino acid that can cause hair loss, thyroid disruption, and reproductive toxicity in mammals at sufficient doses; concentrations in the plant are not quantified in the phytochemical studies reviewed, but the compound is well-documented in agroforestry and veterinary literature as a livestock toxin. High tannin content (up to 209 mg TAE/g in extracts) poses risks of reduced mineral absorption—particularly iron, zinc, and calcium—and potential gastrointestinal irritation, protein precipitation in the gut, and hepatotoxicity at high chronic doses, consistent with the general safety profile of high-tannin botanicals. No formal drug interaction studies exist for matisi; however, based on its phytosterol content, caution is theoretically warranted with cholesterol-lowering medications (statins, ezetimibe), and high tannin content could reduce absorption of oral medications taken concurrently. Given traditional documentation of contraceptive and abortifacient uses, Leucaena leucocephala preparations are contraindicated in pregnancy; no safety data for lactation exist, and internal use by any route is not recommended without further toxicological characterization.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Matisi (Samoan)Giant leucaenaLamtoroIpil-ipilMatisi (Peperomia tetraphylla)Leucaena leucocephalaKoa haoleWhite leadtreeMatisi (Phyllanthus amarus)
Frequently Asked Questions
What is matisi used for in traditional Samoan medicine?
In Samoan traditional medicine, the bark of matisi (Leucaena leucocephala) is applied topically to treat wounds, a use consistent with the stem bark's high content of β-sitosterol (27.2%), betulin (22.1%), and lupeol (21.1%) identified by GC-MS analysis. These triterpenoids and phytosterols possess documented anti-inflammatory and tissue-supportive properties in other plant contexts, providing a plausible phytochemical basis for the wound-care application, though controlled clinical studies on matisi specifically have not been conducted.
Is Leucaena leucocephala safe to consume or use medicinally?
Leucaena leucocephala contains mimosine, a toxic non-protein amino acid documented to cause hair loss, thyroid dysfunction, and reproductive toxicity in livestock and potentially humans at sufficient doses. The plant's very high tannin content (up to 209 mg TAE/g in extracts) also raises concerns about mineral absorption interference and gastrointestinal effects; internal use is not recommended without proper detoxification processing and should be entirely avoided during pregnancy given the plant's traditional use as an abortifacient.
What bioactive compounds are found in Leucaena leucocephala?
GC-MS analysis identified lupeol (14.7–21.1%), betulin (15.7–22.1%), and β-sitosterol (9.1–55.7%) as major triterpenoid and phytosterol constituents across leaves, fruits, and stem bark, with concentrations varying substantially by plant part. LC-MS of pod extracts further identified 54 compounds including sophoranone, hodgkinsine, and calcitriol, while spectrophotometric assays quantified total tannins up to 209.05 mg TAE/g and total flavonoids at 77.95 mg QE/g in pod extracts.
Does Leucaena leucocephala have scientifically proven antioxidant effects?
In vitro antioxidant activity has been demonstrated for Leucaena leucocephala pod extracts, with a DPPH radical scavenging IC50 of 38.68 ± 0.20 µg/mL, and leaf extracts showed high condensed tannin content (up to 140 mg catechin equivalents/g in ethanolic extracts) that correlates with free radical neutralization capacity. However, these are cell-free laboratory assays and do not establish antioxidant efficacy in humans; no clinical trials have measured in vivo antioxidant outcomes in human subjects.
Can Leucaena leucocephala be used as an anticancer treatment?
Current evidence for anticancer potential in Leucaena leucocephala is limited to in silico (computational) molecular docking studies showing that pod-derived compounds including atovaquone, sophoranone, and oxmetidine bind to Topoisomerase II and AKT1—proteins involved in cancer cell proliferation—with stable molecular dynamics profiles. These computational findings have not been validated in cell culture, animal models, or human clinical trials, and Leucaena leucocephala should not be used as a cancer treatment; it remains a candidate for early-stage pharmacological investigation only.
What is the difference between using Leucaena leucocephala stem bark versus leaf extracts?
Leucaena leucocephala stem bark is traditionally used for wound healing and contains high concentrations of phytosterols (β-sitosterol, betulin, and lupeol totaling over 70%) that support anti-inflammatory and tissue-repair mechanisms, while leaf extracts are primarily valued for their antioxidant activity due to high condensed tannin content (137.52 mg/g). The stem bark appears more suited for topical wound applications, whereas leaf extracts may be better for systemic antioxidant support. The choice between forms depends on whether the intended benefit is localized wound healing or general oxidative stress reduction.
How much matisi stem bark should be used for wound healing applications?
Traditional Samoan medicine applies Leucaena leucocephala stem bark topically as a poultice or decoction directly to wounds, though specific standardized dosages for modern use have not been established in clinical literature. The bioactive compounds (phytosterols and phenolics) are thought to be most effective when applied directly to affected areas rather than taken internally for localized wound repair. Consultation with a practitioner experienced in Pacific ethnobotanical medicine is recommended to determine appropriate preparation concentration and application frequency for individual cases.
Is Leucaena leucocephala safe to use on open wounds or broken skin?
While traditional Samoan medicine has used Leucaena leucocephala stem bark topically on wounds for generations, scientific safety data specifically for broken skin or open wounds is limited. The presence of tannins and phytosterols suggests potential benefits for wound healing, but tannins can also cause irritation in some individuals or delay healing if improperly prepared. It is advisable to perform a patch test on a small area of intact skin first and consult a healthcare provider before applying to open wounds, particularly if infection risk is present.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w matisi-leucaena-leucocephala curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
